Patients at pediatric intensive care units who received daily chlorhexidine gluconate baths had significantly lower incidence of bacteremia than patients in the standard bathing protocol group, according to a study in The Lancet. The incidence of skin reactions associated with the antiseptic bathing was 1.2 per 1,000 days, and researchers reported no serious adverse events.